OGSIVEO (NIROGACESTAT HYDROBROMIDE) — FDA Approval NDA217677 (SPRINGWORKS)
OGSIVEO (NIROGACESTAT HYDROBROMIDE) — FDA Approval NDA217677 (SPRINGWORKS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OGSIVEO; Active ingredients: NIROGACESTAT HYDROBROMIDE; Application number: NDA217677.
| Brand name | OGSIVEO |
|---|---|
| Active ingredients | NIROGACESTAT HYDROBROMIDE |
| Application number | NDA217677 |
| Sponsor | SPRINGWORKS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20231127 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →